SGMT financials
Sagimet Biosciences (SGMT) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
SGMT income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$56.89M | -$51.04M | -1.58 |
| 2024 | – | – | -$54.45M | -$45.57M | -1.45 |
| 2023 | $2.00M | – | -$30.74M | -$27.88M | -2.66 |
| 2022 | – | – | -$31.05M | -$30.50M | -165.20 |